Showing results (131-140 of 209) with videos related to
Sort By:
Pageof 21
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2020
Structural basis of Chikungunya virus inhibition by monoclonal antibodiesQun Fei Zhou, Julie M Fox, James T Earnest, et al.Plos Pathogens|May 5, 2020
Human monoclonal antibodies against Ross River virus target epitopes within the E2 protein and protect against diseaseLaura A Powell, Julie M Fox, Nurgun Kose, et al.Nature|November 19, 2010
2'-O methylation of the viral mRNA cap evades host restriction by IFIT family membersStephane Daffis, Kristy J Szretter, Jill Schriewer, et al.Cell Reports|February 16, 2023
Zika virus spreads through infection of lymph node-resident macrophagesGlennys V Reynoso, David N Gordon, Anurag Kalia, et al.The Journal of Experimental Medicine|April 8, 2021
Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flavivirusesLaura A VanBlargan, John M Errico, Natasha M Kafai, et al.Journal of Virology|August 4, 2021
Levels of Circulating NS1 Impact West Nile Virus Spread to the BrainAlex W Wessel, Kimberly A Dowd, Scott B Biering, et al.Vaccine|November 6, 2025
Summary of human West Nile virus vaccine meeting, 2024: Investigating barriers to developmentRandall J Nett, Aaron C Brault, Amy J Lambert, et al.Cell Reports|July 26, 2016
Pathogenic Chikungunya Virus Evades B Cell Responses to Establish PersistenceDavid W Hawman, Julie M Fox, Alison W Ashbrook, et al.Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2015
Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritisJonathan J Miner, Han-Xian Aw-Yeang, Julie M Fox, et al.Vaccines|February 26, 2025
Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan CohortGerald Kevin Oluka, Jackson Sembera, Joseph Ssebwana Katende, et al.Pageof 21